RhumbLine Advisers’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$88.5M Buy
183,274
+24,634
+16% +$6.54M 0.07% 245
2026
Q1
$17.4M Buy
158,640
+5,165
+3% +$736K 0.01% 781
2025
Q4
$25.5M Buy
153,475
+14,249
+10% +$2.38M 0.02% 605
2025
Q3
$27.3M Sell
139,226
-18,658
-12% -$3.07M 0.02% 589
2025
Q2
$14.3M Buy
157,884
+53,539
+51% +$4.23M 0.01% 898
2025
Q1
$6.23M Buy
104,345
+4,396
+4% +$407K 0.01% 1243
2024
Q4
$13.2M Buy
99,949
+78,746
+371% +$7.39M 0.01% 919
2024
Q3
$1.11M Buy
21,203
+4,530
+27% +$213K ﹤0.01% 2214
2024
Q2
$1.01M Buy
+16,673
New +$1.16M ﹤0.01% 2240

Other funds holding ALAB

RhumbLine Advisers's ALAB Position: Q2 2026 in Review

RhumbLine Advisers increased its Astera Labs (ALAB) stake by 16% in Q2 2026, buying an estimated $6.54M and bringing the position to 183,274 shares worth $88.5M. The position accounts for 0.07% of the portfolio, ranked #245.

RhumbLine Advisers first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • RhumbLine Advisers held 183,274 shares of Astera Labs worth $88.5M as of Q2 2026.
  • RhumbLine Advisers bought 24,634 Astera Labs shares in Q2 2026, an estimated $6.54M.
  • Astera Labs made up 0.07% of RhumbLine Advisers's portfolio in Q2 2026, its #245 holding.
  • RhumbLine Advisers first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.